Atlas Trials

Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain

Clinical trial NCT05909709 · RECRUITING

Trial details

NCT number
NCT05909709
Sponsor
Alimorad Farshchian
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Facet Joints; DegenerationBack PainFacet Joint Pain
Start date
2024-04-29
Primary completion
2026-10-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.